The Price of Remission
39 comments
·May 8, 2025comrade1234
My wife’s company developed a multiple myeloma immunotherapy that is for people that have had previous treatments of other drugs but then go into remission.
It works so well that their efficacy reports have caveats like “not enough patients that were treated have died yet” to provide meaningful statistics.
The drug was initially developed in china. They presented results at a conference in the USA but no one believed them other than a skeptical Pfizer who sent a big team to china to confirm the data. Pfizer soon invested billions into the company and drug to bring it to market.
The drug’s sales are on track to be $1 billion this year but the stock is heavily depressed because of the china connection.
csours
Remember the time that Florida fought the federal government for access to socialized medicine?
https://www.flgov.com/eog/news/press/2024/florida-becomes-fi...
> "Today, the DeSantis administration received U.S. Food and Drug Administration (FDA) approval of its Canadian Prescription Drug Importation Program. The Agency for Health Care Administration (AHCA) submitted this first-of-its-kind plan to safely import cheaper drugs from Canada to the FDA nearly 37 months ago, and after filing a lawsuit against the FDA due to delays, has finally received approval. This approval will save Florida up to $180 million in the first year."
planck_tonne
Crazy how they managed to restrict the competing researchers from obtaining the drug.
How did they do that?
Why is the sale of a super expensive drug used exclusively to treat a super specific type of cancer even controlled in the first place? What is even the argument?
I couldn't think of any argument before. After reading, I can only think of "to restrict competition".
throwanem
The argument in essence is that only permitting pharmaceutical companies these outrageous profits will induce them to continue investing the likewise outrageous costs of new drug development now that all the low-hanging fruit like antibiotics, and sildenafil and other antihypertensives, has been picked. This extends (usually by implication) to trivial variations in molecular chemistry which have no functional effect on a medication but which are used to extend patent protections solely on the basis of a structural change - a practice also visible in the history of one family of drugs I have mentioned, and one which without some sort of justification might be taken for an example of a law's letter being abused to violate that same law's intent.
Look, I didn't say I buy it. But you asked for the basic argument advocates make in support of such practices, and here it is.
throwawaymaths
it's not a great argument since iirc half of pharmaceutical company spending is on marketing; far far outstripping r&d
bschne
2024 numbers -- Selling, General & Admin vs. R&D
Roche (Pharma Division): 7533 MCHF vs. 11096 MCHF
Novartis: 12566 MUSD vs. 10022 MUSD
Pfizer: 14730 MUSD vs. 10822 MUSD
Eli Lilly: 8594 MUSD vs. 10991 MUSD
AstraZeneca: 19977 MUSD vs. 13583 MUSD
Johnson & Johnson: 22869 MUSD vs. 17232 MUSD
The left side here contains more than just marketing, and already "far far outstripping" seems like a mischaracterization.
For comparison, the average R&D spend between these firms is bigger than the 2024 NSF budget (~9bn) and bigger than 1/4 of the 2024 NIH budget (~37bn).
tough
the argument might be, the more profits the pharma's make, the more available cash to buy out poltiicians or create SuperPAC's or whatever they have at hand..
America, the land of the dollar
smt88
And a lot of pharma research is based on publicly-funded research in the first place.
jmward01
This is trickle down economics for healthcare. It is stupid. No, it is worse than that, it is evil.
leereeves
> This extends (usually by implication) to trivial variations in molecular chemistry which have no functional effect on a medication but which are used to extend patent protections solely on the basis of a structural change
How does that work? Does it extend patent protection on the original molecule? Or if not, what stops generic copies of the original version?
photochemsyn
Bayh-Dole legislation in the 1990s allowed universities to exclusively license researcher inventions to private parties. Hence:
> "Celgene had acquired the rights to thalidomide patents held by researchers at Rockefeller University in 1992."
Change Bayh-Dole law to non-exclusive licensing, but with some level of royalties paid to institution that originated the patent, and other corporations could have made the drug - and it would be a competitive market, so costs would drop due to lack of a monopoly on the drug.
This one simple change to Bayh-Dole - 'non-exclusive' - would upset the academic-corporate apple cart well beyond pharmaceuticals. Eg the PageRank algorithm created at Stanford could not have been exclusive licensed to Google - any American corporation or person could have applied for a license to the invention, entirely erasing the benefits of a monopolistic patent to the corporation.
One great benefit of this change is that corporations who wanted exclusive patents would have to finance their own private R & D divisions, instead of just capturing the output of taxpayer-financed researchers.
y-curious
It makes me wonder, is there a way to get this drug from a Chinese or Indian lab? I'm sure there are severe legal repercussions, but purely theoretically. It reminds me of the film The Dallas Buyers' Club
the_pwner224
Yes, it's readily available to buy online from India for <$1/pill.
In practice there aren't legal repercussions. If you import scheduled drugs (adderall, opioids, etc.) and get caught that's obviously going to be a big issue. But with most prescription medications, the worst case scenario is that Customs will just toss your package. And the likelihood of that is low; the majority of the time it makes it through undetected.
I've done this in the past with another drug. In the US it was $30/month but from India I got 1000 pills for $30 + $40 expedited shipping. For me the big factor wasn't cost, but rather the convenience of not needing to go through the process of getting a prescription.
null
> But Revlimid is also, I soon learned, extraordinarily expensive, costing nearly $1,000 for each daily pill.
Thanks to the bargaining power of my nationalised healthcare, my government pays around 1/5th of that, and I'll pay nothing myself.
Revlamid is listed under it's generic name Lenalidomide, price is in pence: https://www.drugtariff.nhsbsa.nhs.uk/#/00791628-DD/DD0079145...